(For treatment side effects and complications only)
ATEZOLIZUMAB AND BEVACIZUMAB Hepatocellular carcinoma V1.1
Capecitabine Protocol V3.2
Entrectinib - NTRK Gene Fusion-positive Solid Tumours ROS1-positive NSCLC Protocol V1.1
Larotrectinib NTRK Gene Fusion-positive Solid Tumours Protocol V1.0
LENVATINIB (Lenvima) Hepatocellular Carcinoma Protocol V1.0
Regorafenib Protocol V2.0
Sorafenib Hepatocellular Carcinoma Protocol V1.0